Myriad's myChoice To Be Used In More Cancer Clinical Trials
This article was originally published in The Gray Sheet
Myriad is continuing its mission to expand its companion diagnostics reach by teaming up with Tesaro and Merck to evaluate their breast and ovarian cancer drugs, and expanding its partnership with Abbvie into lung cancer. .
Register for our free email digests: